Maso Capital Partners’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Maso Capital Partners’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-627,111	Closed	-$74.3M	–	63
2021 Q1	$74.3M	Hold	627,111	–	–	28.61%	1
2020 Q4	$74.1M	Sell	627,111 -255,300	-29%	-$29.6M	20.2%	2
2020 Q3	$98.1M	Sell	882,411 -66,218	-7%	-$7.11M	54.82%	1
2020 Q2	$96.9M	Buy	948,629 +20,613	+2%	+$2.21M	39.11%	1
2020 Q1	$100M	Buy	928,016 +388,419	+72%	+$44.6M	25.94%	2
2019 Q4	$62.8M	Buy	539,597 +316,197	+142%	+$36.6M	20.19%	2
2019 Q3	$25.6M	Buy	223,400 +72,366	+48%	+$7.2M	9.19%	3
2019 Q2	$14.4M	Sell	151,034 -13,466	-8%	-$1.27M	7.55%	4
2019 Q1	$15M	Buy	164,500 +5,300	+3%	+$434K	10.32%	4
2018 Q4	$12.1M	Buy	159,200 +15,900	+11%	+$1.17M	15.17%	2
2018 Q3	$11.5M	Buy	+143,300	New	+$13.4M	11.16%	3

Maso Capital Partners's CBPO Position: Q2 2021 in Review

Maso Capital Partners sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2021, closing a stake of 627,111 shares — an estimated $74.3M sold.

Maso Capital Partners first reported a position in CBPO in Q3 2018 and held it in 11 quarters. The position peaked at $100M in Q1 2020. 0 funds tracked by Wall St. Rank hold CBPO as of Q2 2021.

Maso Capital Partners reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2021 after selling out during the quarter.
Maso Capital Partners sold 627,111 China Biologic Products Holdings, Inc. shares in Q2 2021, an estimated $74.3M.
Maso Capital Partners first reported a position in China Biologic Products Holdings, Inc. in Q3 2018 and held it in 11 quarters.
Maso Capital Partners's China Biologic Products Holdings, Inc. position peaked at $100M in Q1 2020.
0 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2021.

Based on Maso Capital Partners's 13F filing for Q2 2021, filed 16 Aug 2021.